Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-10-23
2007-10-23
Kemmerer, Elizabeth C. (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S008100
Reexamination Certificate
active
10735345
ABSTRACT:
Methods of treating and/or inhibiting a bone morphogenetic protein (BMP)-related disorder or condition by administering a BMP antagonist to a subject suffering from a BMP-related disorder or condition such that the BMP-related disorder or condition is treated. The method is carried out with a human noggin or a human noggin deletion mutant.
REFERENCES:
patent: 4857637 (1989-08-01), Hammonds et al.
patent: 4933294 (1990-06-01), Waterfield et al.
patent: 5030576 (1991-07-01), Dull et al.
patent: WO 92/00524 (1992-04-01), None
Yanagita, 2005, Cytokine and Growth Factor Reviews 16:309-317.
Wells, 1990, Biochemistry 29:8509-8517.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Bork, 2000, Genome Research 10:398-400.
Skolnick et al., 2000, Trends in Biotech. 18(1):34-39.
Doerks et al., 1998, Trends in Genetics 14:248-250.
Smith et al., 1997, Nature Biotechnology 15:1222-1223.
Brenner, 1999, Trends in Genetics 15:132-133.
Bork et al., 1996, Trends in Genetics 12:425-427.
Zimmerman et al., 1996, Cell 86:599-606.
Hanallah et al., 2004, J. Bone Joint Surg. 86 :80-91.
Glaser et al., 2003, J. Bone Joint Surg. 85 :2332-2342.
Waite et al., 2003, Nature Reviews Genetics 4(10):763-773.
DEVELOPMENT, vol. 111, issued 1991, Christian, J., et al., “Xwnt-8, a Xenopus Wnt-1/int-1 related gene responsive to mesoderm-inducing growth factors, may play a role in ventral mesodermal patterning during embryogenesis,” pp. 1045-1055.
NATURE, vol. 361, issued Feb. 11, 1993, Smith, W.C., et al., “Secreted noggin protein mimics the Spemann organizer in dorsalizingXenopus mesoderm,” pp. 547-549.
CELL, vol. 67, issued Nov. 15, 1991, Smith, W.C., and Harland, R.M., “Injected Xwnt-8 RNA Acts Early in Xenopus Embryos to Promote Formation of a Vegetal Dorsalizing Center”, pp. 753-765.
Brunet et al., Science, vol. 280, pp. 1455-1457, 1998.
Jackowski, A., British J. of Neurosurgery, vol. 9, pp. 303-317, 1995.
Pepeu, G., et al., Drug Design and Delivery, vol. 7, pp. 1-10, 1990.
Economides Aris N.
Stahl Neil
Valenzuela David M.
Yancopoulos George D.
Gregg, Esq. Valeta
Kemmerer Elizabeth C.
Regeneron Pharmaceuticals Inc.
Smeland, Esq. Tor E.
LandOfFree
Therapeutic method for treating bone formation diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic method for treating bone formation diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic method for treating bone formation diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3857630